Cervomed to participate in the canaccord genuity 44th annual growth conference

Boston, july 30, 2024 (globe newswire) -- cervomed inc. (nasdaq: crvo), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that company's management will participate in a fireside chat at the canaccord genuity 44th annual growth conference, to be held in boston, ma, and participate in one-on-one investor meetings.
CRVO Ratings Summary
CRVO Quant Ranking